References: Allen, A.P., Dinan, T.G., Clarke, G., Cryan, J.F., A psychology of the human brain-gut-microbiome axis (2017) Social and Personality Psychology Compass, 11 (4), p. e12309;
Andrykowski, M.A., Steffens, R.F., Bush, H.M., Tucker, T.C., Posttraumatic growth and benefit-finding in lung cancer survivors: The benefit of rural residence? (2017) Journal of Health Psychology, 22 (7), pp. 896-905;
Antoine, P., Dauvier, B., Andreotti, E., Congard, A., Individual differences in the effects of a positive psychology intervention: Applied psychology (2018) Personality and Individual Differences, 122, pp. 140-147;
(2013) Diagnostic and statistical manual of mental disorders, , 5th ed., American Psychiatric Association;
Barch, D.M., Harms, M.P., Tillman, R., Hawkey, E., Luby, J.L., Early childhood depression, emotion regulation, episodic memory, and hippocampal development (2019) Journal of Abnormal Psychology, 128 (1), pp. 81-95;
Beck, A.T., Bredemeier, K., A unified model of depression: Integrating clinical, cognitive, biological, and evolutionary perspectives (2016) Clinical Psychological Science, 4 (4), pp. 596-619;
Beck, A.T., Steer, R.A., Ball, R., Ranieri, W.F., Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients (1996) Journal of Personality Assessment, 67 (3), pp. 588-597;
Beleckas, C.M., Guattery, J., Chamberlain, A.M., Khan, T., Kelly, M.P., Calfee, R.P., Using patient-reported outcomes measurement information system measures to understand the relationship between improvement in physical function and depressive symptoms (2018) Journal of the American Academy of Orthopaedic Surgeons, 26 (24), pp. e511-e518;
Belujon, P., Grace, A.A., Dopamine system dysregulation in major depressive disorders (2017) The International Journal of Neuropsychopharmacology, 20 (12), pp. 1036-1046;
Bernaras, E., Jaureguizar, J., Garaigordobil, M., Child and adolescent depression: A review of theories, evaluation instruments, prevention programs, and treatments (2019) Frontiers in Psychology, 10, p. 543;
Bigelow, A.E., Beebe, B., Power, M., Stafford, A.-L., Ewing, J., Egleson, A., Kaminer, T., Longitudinal relations among maternal depressive symptoms, maternal mind-mindedness, and infant attachment behavior (2018) Infant Behavior & Development, 51, pp. 33-44;
Boku, S., Nakagawa, S., Toda, H., Hishimoto, A., Neural basis of major depressive disorder: Beyond monoamine hypothesis (2018) Psychiatry and Clinical Neurosciences, 72 (1), pp. 3-12;
Brummelte, S., Galea, L.A.M., Postpartum depression: Etiology, treatment and consequences for maternal care (2016) Hormones and Behavior, 77, pp. 153-166;
Caspani, G., Kennedy, S., Foster, J.A., Swann, J., Gut microbial metabolites in depression: Understanding the biochemical mechanisms (2019) Microbial Cell (Graz, Austria), 6 (10), pp. 454-481;
Celano, C.M., Villegas, A.C., Albanese, A.M., Gaggin, H.K., Huffman, J.C., Depression and anxiety in heart failure: A review (2018) Harvard Review of Psychiatry, 26 (4), pp. 175-184;
Cella, D., Lai, J.S., Nowinski, C.J., Victorson, D., Peterman, A., Miller, D., Bethoux, F., Moy, C., Neuro-QOL: Brief measures of health-related quality of life for clinical research in neurology (2012) Neurology, 78 (23), pp. 1860-1867. , …;
Cepeda, M.S., Katz, E.G., Blacketer, C., Microbiome-gut-brain axis: Probiotics and their association with depression (2017) The Journal of Neuropsychiatry and Clinical Neurosciences, 29 (1), pp. 39-44;
Chen, T., Noto, D., Hoshino, Y., Mizuno, M., Miyake, S., Butyrate suppresses demyelination and enhances remyelination (2019) Journal of Neuroinflammation, 16 (1), pp. 113-165;
Chiu, M., Lebenbaum, M., Cheng, J., de Oliveira, C., Kurdyak, P., The direct healthcare costs associated with psychological distress and major depression: A population-based cohort study in Ontario, Canada (2017) PLOS One, 12 (9);
Chow, W., Doane, M.J., Jack, S., Alphs, L., Le, H., (2019), https://www.ajmc.com/view/economic-burden-mdd, Economic burden among patients with major depressive disorder: An analysis of healthcare resource use, work productivity, and direct and indirect costs by depression severity., The American Journal of Managed Care; Cooper, J.A., Arulpragasam, A.R., Treadway, M.T., Anhedonia in depression: Biological mechanisms and computational models (2018) Current Opinion in Behavioral Sciences, 22, pp. 128-135;
Correll, C.U., Schooler, N.R., Negative symptoms in schizophrenia: A review and clinical guide for recognition, assessment, and treatment (2020) Neuropsychiatric Disease and Treatment, 16, pp. 519-534;
Cox, L.M., Weiner, H.L., Microbiota signaling pathways that influence neurologic disease (2018) Neurotherapeutics, 15 (1), pp. 135-145;
Dantzer, R., Meagher, M.W., Cleeland, C.S., Translational approaches to treatment-induced symptoms in cancer patients (2012) Nature Reviews Clinical Oncology, 9 (7), pp. 414-426;
Dunlop, B.W., LoParo, D., Kinkead, B., Mletzko-Crowe, T., Cole, S.P., Nemeroff, C.B., Mayberg, H.S., Craighead, W.E., Benefits of sequentially adding cognitive-behavioral therapy or antidepressant medication for adults with nonremitting depression (2019) The American Journal of Psychiatry, 176 (4), pp. 275-286;
Dunn, E.C., Brown, R.C., Dai, Y., Rosand, J., Nugent, N.R., Amstadter, A.B., Smoller, J.W., Genetic determinants of depression: Recent findings and future directions (2015) Harvard Review of Psychiatry, 23 (1), pp. 1-18;
Egede, L.E., Bishu, K.G., Walker, R.J., Dismuke, C.E., Impact of diagnosed depression on healthcare costs in adults with and without diabetes: United States, 2004-2011 (2016) Journal of Affective Disorders, 195, pp. 119-126;
(1998) Effective Public Health Practice Project. Quality assessment tool for quantitative studies, , http://www.ephpp.ca/PDF/Quality%20Assessment%20Tool_2010_2.pdf;
Ghaisas, S., Maher, J., Kanthasamy, A., Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases (2016) Pharmacology & Therapeutics, 158, pp. 52-62;
Grzesiak, M., Beszłej, J.A., Waszczuk, E., Szechiński, M., Szewczuk-Bogusławska, M., Frydecka, D., Dobosz, T., Mulak, A., Serotonin-related gene variants in patients with irritable bowel syndrome and depressive or anxiety disorders (2017) Gastroenterology Research and Practice, 2017, pp. 4290430-4290439;
Hartung, T.J., Brähler, E., Faller, H., Härter, M., Hinz, A., Johansen, C., Keller, M., Mehnert, A., The risk of being depressed is significantly higher in cancer patients than in the general population: Prevalence and severity of depressive symptoms across major cancer types (2017) European Journal of Cancer (Oxford, England: 1990), 72, pp. 46-53;
(2016), https://www.healthevidence.org/documents/our-appraisal-tools/QA_Tool&Dictionary_10Nov16.pdf, Helping public health use best evidence practice since 2005: Quality Assessment ToolReview articles,. Health Evidence; Hek, K., Demirkan, A., Lahti, J., Terracciano, A., Teumer, A., Cornelis, M.C., Amin, N., Murabito, J., A genome-wide association study of depressive symptoms (2013) Biological Psychiatry, 73 (7), pp. 667-678. , …;
Helal, S.I., Lee, G., Evans, C., Grealish, A., The efficacy of psychological interventions on health-related quality of life for patients with heart failure and depression: A systematic review (2020) Journal of Cardiovascular Nursing;
Hodes, G.E., Kana, V., Menard, C., Merad, M., Russo, S.J., Neuroimmune mechanisms of depression (2015) Nature Neuroscience, 18 (10), pp. 1386-1393;
Keller, S., Yang, M., Treadwell, M.J., Hassell, K.L., Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: Comparison of PROMIS® to ASCQ-Me (2017) Health and Quality of Life Outcomes, 15 (1), p. 117;
Kneipp, S.M., Kairalla, J.A., Stacciarini, J., Pereira, D., The Beck Depression Inventory II factor structure among low-income women (2009) Nursing Research, 58 (6), pp. 400-409;
Lee, S.-A., Jeon, J.Y., No, S.-K., Park, H., Kim, O.-J., Kwon, J.-H., Jo, K.-D., Factors contributing to anxiety and depressive symptoms in adults with new-onset epilepsy (2018) Epilepsy & Behavior, 88, pp. 325-331;
Levis, B., Benedetti, A., Thombs, B.D., Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: Individual participant data meta-analysis (2019) BMJ (Clinical Research ed.), 365, p. l1476;
Liang, S., Wu, X., Hu, X., Wang, T., Jin, F., Recognizing depression from the microbiota–gut–brain axis (2018) International Journal of Molecular Sciences, 19 (6), p. 1592;
Liu, B., Liu, J., Wang, M., Zhang, Y., Li, L., From serotonin to neuroplasticity: Evolvement of theories for major depressive disorder (2017) Frontiers in Cellular Neuroscience, 11, p. 305;
Marathe, S.V., D’almeida, P.L., Virmani, G., Bathini, P., Alberi, L., Effects of monoamines and antidepressants on astrocyte physiology: Implications for monoamine hypothesis of depression (2018) Journal of Experimental Neuroscience, 12. , 1179069518789149;
McCabe, B.E., Vermeesch, A.L., Hall, R.F., Peragallo, N.P., Mitrani, V.B., Acculturation and the Center for Epidemiological Studies-Depression Scale for Hispanic women (2011) Nursing Research, 60 (4), pp. 270-275;
McGrath, C.L., Kelley, M.E., Holtzheimer, P.E., Dunlop, B.W., Craighead, W.E., Franco, A.R., Craddock, R.C., Mayberg, H.S., Toward a neuroimaging treatment selection biomarker for major depressive disorder (2013) JAMA Psychiatry, 70 (8), pp. 821-829;
Miller, A.H., Haroon, E., Raison, C.L., Felger, J.C., Cytokine targets in the brain: Impact on neurotransmitters and neurocircuits (2013) Depression and Anxiety, 30 (4), pp. 297-306;
Mohajeri, M.H., La Fata, G., Steinert, R.E., Weber, P., Relationship between the gut microbiome and brain function (2018) Nutrition Reviews, 76 (7), pp. 481-496;
(2020), https://www.nature.com/subjects/machine-learning, Machine learning,. Springer, Limited; Ng, Q.X., Peters, C., Ho, C.Y.X., Lim, D.Y., Yeo, W.-S., A meta-analysis of the use of probiotics to alleviate depressive symptoms (2018) Journal of Affective Disorders, 228, pp. 13-19;
(2020), https://www.genome.gov/genetics-glossary/Single-Nucleotide-Polymorphisms, Single nucleotide polymorphisms (SNPs),. National Institute of Health; Obrenovich, M., Leaky gut, leaky brain? (2018) Microorganisms, 6 (4), p. 107;
Okbay, A., Baselmans, B.M.L., De Neve, J.-E., Turley, P., Nivard, M.G., Fontana, M.A., Meddens, S.F.W., Cesarini, D., Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses (2016) Nature Genetics, 48 (6), pp. 624-633. , …;
Otte, C., Gold, S.M., Penninx, B.W., Pariante, C.M., Etkin, A., Fava, M., Mohr, D.C., Schatzberg, A.F., Major depressive disorder (2016) Nature Reviews Disease Primers, 2, p. 16065;
Porgo, T.V., Norris, S.L., Salanti, G., Johnson, L.F., Simpson, J.A., Low, N., Egger, M., Althaus, C.L., The use of mathematical modeling studies for evidence synthesis and guideline development: A glossary (2019) Research Synthesis Methods, 10 (1), pp. 125-133;
Roy, M., Tapadia, M.G., Joshi, S., Koch, B., Molecular and genetic basis of depression (2014) Journal of Genetics, 93 (3), pp. 879-892;
Rugulies, R., Sørensen, K., Aldrich, P.T., Folker, A.P., Friborg, M.K., Kjaer, S., Nielsen, M.B.D., Madsen, I.E.H., Onset of workplace sexual harassment and subsequent depressive symptoms and incident depressive disorder in the Danish workforce (2020) Journal of Affective Disorders, 277, pp. 21-29;
Searight, H.R., Montone, K., Profile of mood states (2017) Encyclopedia of personality and individual differences, , Zeigler-Hill V., Shackelford T.K., (eds), Springer, &,. (Eds;
Shadrina, M., Bondarenko, E.A., Slominsky, P.A., Genetics factors in major depression disease (2018) Frontiers in Psychiatry, 9, p. 334;
Sim, J.A., Young Ae, K., Kim, J.H., Lee, J.M., Kim, M.S., Shim, Y.M., Zo, J.I., Yun, Y.H., The major effects of health-related quality of life on 5-year survival prediction among lung cancer survivors: Applications of machine learning (2020) Scientific Reports, 10 (1), p. 10693;
Smarr, K.L., Keefer, A.L., Measures of depression and depressive symptoms: Beck Depression Inventory‐II (BDI‐II), Center for Epidemiologic Studies Depression Scale (CES‐D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire‐9 (PHQ‐9) (2011) Arthritis Care & Research, 63 (S11), pp. S454-S466;
Smith, L.K., Wissel, E.F., Microbes and the mind: How bacteria shape affect, neurological processes, cognition, social relationships, development, and pathology (2019) Perspectives on Psychological Science, 14 (3), pp. 397-418;
Solis, E., Antypa, N., Conijn, J.M., Kelderman, H., Van der Does, W., Psychometric properties of the Leiden Index of Depression Sensitivity (LEIDS) (2017) Psychological Assessment, 29 (2), pp. 158-171;
Strawbridge, R., Young, A.H., Cleare, A.J., Biomarkers for depression: Recent insights, current challenges and future prospects (2018) Focus (American Psychiatric Publishing), 16 (2), pp. 194-209;
Swardfager, W., Rosenblat, J.D., Benlamri, M., McIntyre, R.S., Mapping inflammation onto mood: Inflammatory mediators of anhedonia (2016) Neuroscience and Biobehavioral Reviews, 64, pp. 148-166;
Thomas, B.H., Ciliska, D., Dobbin, M., Micucci, S., A process for systematically reviewing the literature: Providing the research evidence for public health nursing interventions (2004) Worldviews on Evidence-Based Nursing, 1 (3), pp. 176-184;
Tobias, K.G., Lehrfeld, J., Rosenfeld, B., Pessin, H., Breitbart, W., Confirmatory factor analysis of the Beck Depression Inventory–II in patients with advanced cancer: A theory-driven approach (2017) Palliative and Supportive Care, 15 (6), pp. 704-709;
Wallace, C.J.K., Milev, R., Erratum to: The effects of probiotics on depressive symptoms in humans: A systematic review (2017) Annals of General Psychiatry, 16 (1), pp. 10-18;
Wang, J., Wu, X., Lai, W., Long, E., Zhang, X., Li, W., Zhu, Y., Lin, H., Prevalence of depression and depressive symptoms among outpatients: A systematic review and meta-analysis (2017) BMJ Open, 7 (8), p. e017173;
Wardenaar, K.J., Riese, H., Giltay, E.J., Eikelenboom, M., van Hemert, A.M., Beekman, A., Penninx, B., Schoevers, R., Common and specific determinants of 9-year depression and anxiety course-trajectories: A machine-learning investigation in the Netherlands Study of Depression and Anxiety (NESDA) (2021) Journal of Affective Disorders, 293, pp. 295-304;
(2020) Depression, , https://www.who.int/news-room/fact-sheets/detail/depression;
Winer, E.S., Jordan, D.G., Collins, A.C., Conceptualizing anhedonias and implications for depression treatments (2019) Psychology Research and Behavior Management, 12, pp. 325-335;
Wise, R.A., Dopamine and reward: The anhedonia hypothesis 30 years on (2008) Neurotoxicity Research, 14 (2-3), pp. 169-183;
Xia, J., Lu, Z., Feng, S., Yang, J., Ji, M., Different effects of immune stimulation on chronic unpredictable mild stress-induced anxiety- and depression-like behaviors depending on timing of stimulation (2018) International Immunopharmacology, 58, pp. 48-56;
Xue, R., Zhang, H., Pan, J., Du, Z., Zhou, W., Zhang, Z., Tian, Z., Bai, L., Peripheral dopamine controlled by gut microbes inhibits invariant natural killer T Cell-Mediated Hepatitis (2018) Frontiers in Immunology, 9, p. 2398;
Yarlagadda, A., Alfson, E., Clayton, A.H., The blood brain barrier and the role of cytokines in neuropsychiatry (2009) Psychiatry (Edgmont), 6 (11), pp. 18-22;
Zamani, M., Alizadeh-Tabari, S., Zamani, V., Systematic review with meta-analysis: The prevalence of anxiety and depression in patients with irritable bowel syndrome (2019) Alimentary Pharmacology & Therapeutics, 50 (2), pp. 132-143
